Axsome Therapeutics (19X) Revenue

1 Followers

Axsome Therapeutics Revenue

Axsome Therapeutics had a revenue of 218.38M in the quarter ending Jun 30, 2026, with 14.21%. This bring the company's revenue in the last twelve months to 776.57M, Decreased 9.65%. In the fiscal year ending Dec 31, 2025, Axsome Therapeutics had annual revenue of 638.50M with 65.55% growth.

Revenue (ttm)

776.57M

Revenue Growth

46.53%

P/S Ratio

14.58

Revenue/Employee

€474,366

Employees

1,346

Market Cap

€9.31B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	638.50M	252.80M	+65.55%
Dec 31, 2024	385.69M	115.09M	+42.53%
Dec 31, 2023	270.60M	220.56M	+440.80%
Dec 31, 2022	50.04M	―	+∞%
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―